Where vitamin K2 comes from, in real food

Swipe sideways on mobile. Exact K2 content varies widely by product, animal diet and analysis method, so treat these as relative rankings, not precise doses.

Two vitamin Ks, and only one, gets the dental hype

Vitamin K is not a single molecule. It is a family split into two branches that do overlapping but not identical jobs. Vitamin K1, called phylloquinone, is the one packed into leafy greens like kale, spinach and broccoli, and it is best known for its role in blood clotting. Vitamin K2, the menaquinones, comes from fermented foods, certain animal products and bacteria living in your own gut, and it is the branch that gets the attention in bone, heart and dental conversations.

The menaquinones are numbered by the length of their side chain, from MK-4 up to MK-13. Two matter most in practice. MK-4 shows up in animal foods such as egg yolk, butter and some meats, and the body can also make small amounts by converting K1. MK-7, produced by bacteria and concentrated in the Japanese fermented soybean dish natto, is the form most supplements use because it stays in the blood far longer. A small daily dose of MK-7 keeps working across a full day rather than clearing within hours.

That distinction matters for teeth in one blunt way. Most of the population-level evidence tying vitamin K intake to hard, mineralized tissue points to menaquinones, not to the K1 you get from a salad. As the NIH notes, dietary menaquinone intake, but not phylloquinone, has been inversely associated with arterial calcification in observational studies. Whether that pattern extends cleanly to enamel and dentin is a separate question, and a much less settled one.

The practical takeaway. If you eat plenty of greens you are probably covered for K1 and clotting, but that says little about your K2 status. K2 comes from a shorter, less common list of foods, and it is the form the entire tooth and bone story is built on. Getting enough of one does not guarantee enough of the other, and it is the second one that this article is about.

How K2 actually moves calcium, around the body

The reason vitamin K2 keeps appearing in mineral and enamel discussions comes down to one chemical trick. K2 is a cofactor for an enzyme, gamma-glutamyl carboxylase, that performs a modification called carboxylation on a small set of proteins. Carboxylation is the on switch. Without enough K2, these proteins are still made but left in an inactive, uncarboxylated state, floating in your blood but unable to do their calcium handling job.

Two of these vitamin K-dependent proteins matter for hard tissue. The first is osteocalcin, made by the bone-building osteoblasts and, importantly, by the dentin-building odontoblasts inside a tooth. Once K2 activates it, osteocalcin binds calcium and helps incorporate it into the mineralized matrix. The second is matrix Gla protein, or MGP, which does the opposite and equally important job of inhibiting calcification where it does not belong, in arteries, cartilage and other soft tissue. Think of osteocalcin as the protein that files calcium into the right drawer and MGP as the one that stops it piling up on the floor. Both need the same vitamin to function, which is why a shortfall in K2 can affect the two sides of the calcium problem at once.

Put those two together and you get the idea sometimes called the calcium paradox. Calcium itself is neutral cargo. What decides whether it strengthens your skeleton or hardens your arteries is partly whether the K2-dependent traffic proteins are switched on. Peer-reviewed reviews of menaquinone biology describe exactly this: carboxylated osteocalcin helps chelate and import calcium into bone, while carboxylated MGP helps keep it out of vessel walls. This is textbook vitamin K-dependent protein function, not wellness invention.

Here is the honest hinge. Everything above is mechanism, and mechanism is a hypothesis about what should happen, not a measurement of what does happen in your mouth. A protein that can carry calcium into dentin in principle is a strong reason to take K2 seriously. It is not, by itself, evidence that a supplement rebuilds a specific tooth. Keep that distinction close, because a lot of confident dental marketing quietly erases it.

What K2 plausibly does, inside a tooth

A tooth is not one uniform material. The hard outer shell is enamel, which is almost entirely mineral and, crucially, is not living tissue. Enamel has no cells inside it, so it cannot biologically regrow. Once it is gone it is gone, and the only way to add mineral back to its surface is chemically, from the outside, which is what saliva, fluoride and hydroxyapatite do. Vitamin K2 does not act here at all, and any claim that a K2 pill regrows enamel simply misunderstands what enamel is.

Underneath the enamel is dentin, and dentin is a different story. Dentin is living, it contains osteocalcin in its matrix, and it is laid down throughout life by the odontoblast cells lining the pulp. Because osteocalcin is a vitamin K-dependent protein, there is a clean mechanistic argument that adequate K2 supports healthy dentin mineralization, in the same way it supports bone. When decay advances, a tooth can lay down reactionary or tertiary dentin as a defensive response, and that is a living, mineral handling process where K2-dependent proteins plausibly play a part.

So the accurate framing is narrow and specific. K2 is not an enamel surface treatment. Its plausible dental role is systemic support for the mineralized, living parts of the tooth, the dentin and the surrounding bone that holds the tooth in its socket, through the same osteocalcin and MGP pathways that operate elsewhere in the body. That is a modest, believable claim. It is also very different from the headline that K2 heals cavities, which no controlled human trial currently supports.

The gum-line angle people miss. K2 activates MGP, and MGP restrains abnormal calcification of soft tissue. Some of the interest in K2 for oral health is therefore less about the tooth itself and more about the ligament and bone around it, the periodontal support. The evidence here is still early and mostly indirect, borrowed from vascular and skeletal research, so treat it as a reason to keep your K2 status adequate, not as a proven periodontal therapy.

The Weston Price story, and why it is not proof

No K2 conversation stays honest for long without addressing Weston Price. Price was a dentist who, in the first half of the twentieth century, travelled to study populations with strikingly low rates of tooth decay and identified a fat-soluble something in their diets, concentrated in butter from fast-growing spring grass, in fish eggs and in organ meats, that seemed to track with strong teeth. He could not chemically identify it and called it Activator X. Decades later, in 2007, the writer Chris Masterjohn and the Weston A. Price Foundation argued that Activator X was most likely vitamin K2.

This is a genuinely interesting historical thread, and it is where a large share of the modern K2-for-teeth enthusiasm comes from. It is also, by the honest standards of evidence, a hypothesis stacked on an observation. Price's work was observational and of its era, the identification of Activator X as K2 is an educated inference rather than a proven fact, and even the foundation's own writers concede they are not certain the two are the same substance. None of this is worthless. It is simply not a clinical trial.

The reason to be careful is that a compelling origin story can do a great deal of persuasive work that the data has not earned. A historical dentist noticing that certain traditional diets produced good teeth is a legitimate reason to investigate the nutrients in those diets. It is not a reason to promise that a modern capsule reverses decay. A good body of evidence and a good story are different things, and on teeth specifically the K2 field has far more of the second than the first. It is also worth remembering that the low-decay diets Price documented differed from a modern one in dozens of ways at once, from sugar and refined flour to the whole pattern of eating, so pinning the effect on any single fat-soluble factor was always going to be an interpretation rather than a proof.

Hold both ideas at once. The traditional-diet observation can be real and worth taking seriously, and the specific claim that supplementing K2 fixes cavities can still be unproven. Skepticism about the marketing is not the same as dismissing the nutrient. K2 earns a place in a sensible diet on its bone and cardiovascular record alone. The dental part is promising background, not a settled result, and treating it as settled is exactly the error to avoid.

What the human evidence, actually shows

Strip away the mechanism and the history, and here is where the human data actually stands. The strongest evidence for vitamin K2 is skeletal. In Japan, a high-dose MK-4 form, at 45 milligrams a day, has been used as a prescription treatment for osteoporosis, and several trials and meta-analyses report improvements in bone quality and reductions in fracture risk, although the results are not uniform and some large trials have been less impressive. Lower-dose MK-7 studies, closer to nutritional amounts, show improvements in markers of osteocalcin carboxylation and in some measures of bone mineral density over time.

The cardiovascular evidence is largely observational but consistent in direction. The often-cited Dutch population data found that higher dietary menaquinone intake was associated with less arterial calcification and lower coronary heart disease mortality, which fits the MGP mechanism neatly. Reviews combining vitamins K and D argue the two work together on calcium handling, with vitamin D increasing calcium availability and osteocalcin production and K2 activating the proteins that place that calcium correctly.

Now the part the supplement pages tend to skip. There is no comparable body of randomized controlled trials showing that a vitamin K2 supplement prevents or reverses dental caries in humans. The dental literature is dominated by mechanism papers, laboratory and animal work, and extrapolation from the bone and vascular findings. Even enthusiastic clinical write-ups acknowledge that large dental trials are missing and that claims of K2 directly remineralizing teeth are premature. That absence is not proof K2 does nothing for teeth. It is proof that nobody has actually demonstrated that it does.

How to read a confident dental claim. When you see K2 marketed as a cavity fixer, ask what it is citing. Almost always it is a mechanism paper or a bone study, not a dental trial, with the leap from one to the other left unstated. The mechanism is real, the bone evidence is decent, and the direct tooth evidence is thin. An honest page tells you all three. A selling page shows you only the first two and lets you assume the third.

K2 and vitamin D, why they travel together

You rarely read about K2 for long without vitamin D appearing beside it, and there is a real reason for the pairing beyond marketing convenience. Vitamin D's main job in this system is to increase how much calcium you absorb from food and to stimulate the production of osteocalcin. But osteocalcin produced under D's influence is still inactive until K2 carboxylates it. In other words, D can raise the amount of calcium in circulation and the amount of the calcium-binding protein, while K2 is what actually switches that protein on to put the calcium where it belongs.

This is why some reviewers argue that taking high-dose vitamin D without adequate K2 is, at least in theory, an incomplete strategy: you may end up with more calcium mobilized but not enough activated MGP and osteocalcin to direct it, though how much this matters at ordinary nutritional intakes in healthy people is still debated. For teeth and the bone around them, the sensible reading is not to megadose anything but to make sure both nutrients are genuinely present in your diet, because they are two halves of the same calcium-placement mechanism.

Both are fat-soluble, which has a practical consequence people forget. K2 and D are absorbed far better when eaten with some fat. Natto with a meal, cheese, egg yolks and butter naturally come with fat, which is convenient. An isolated supplement swallowed on an empty stomach is absorbed less reliably. Reviews combining vitamins K and D make the same broad point, that these nutrients act as a team on calcium metabolism, so if you are going to bother with K2 at all, pairing it with a meal that contains fat is the single easiest way to make it count.

The restraint worth keeping. Synergy is not a licence to stack high doses of everything. The clean version of this idea is simply that calcium, vitamin D and vitamin K2 form a small team, and a diet short on K2 can leave the other two working with the handbrake half on. Fixing that with food is low-risk. Chasing large supplemental doses of fat-soluble vitamins without a reason is not, and it is where people tend to get into trouble.

Getting K2 from food, without overthinking it

The good news is that fixing a mediocre K2 intake is mostly a grocery problem, not a pharmacy one. Here is where menaquinones actually live, roughly in order of how much they carry, along with the one real safety flag that turns this from a simple diet tweak into a conversation with your doctor.

For most people who eat cheese, eggs and the occasional fermented food, a catastrophic K2 deficiency is unlikely, but a merely adequate intake, enough for clotting yet not optimal for carboxylating osteocalcin and MGP, is plausible and common. That is the realistic target to improve, and food does it without the risks that come from megadosing fat-soluble vitamins you do not actually need.

Who tends to run low, and can you even test it

Overt vitamin K deficiency, the kind that causes bleeding problems, is rare in adults, which is why clinical guidance often treats K status as a solved question. But the amount of K needed to keep your blood clotting normally is lower than the amount needed to fully carboxylate osteocalcin and MGP throughout the body. That gap, adequate for clotting but suboptimal for the bone and tissue proteins, is where the interesting shortfall probably hides, and it does not show up on a standard clotting test.

Certain groups are more likely to sit in that suboptimal zone. People who eat very little dairy, eggs or fermented food have few K2 sources to begin with, and strict plant-based diets without natto or fermented substitutes can be genuinely low. Fat malabsorption conditions, such as celiac disease, inflammatory bowel disease or cystic fibrosis, and anything that reduces bile flow, impair absorption of all fat-soluble vitamins including K. Long courses of broad-spectrum antibiotics can knock back the gut bacteria that make some menaquinones. And people on strict low-fat diets may absorb less of what they do manage to eat, because the vitamin needs dietary fat to come along for the ride.

Can you measure it. Sort of, but not with a routine blood test for vitamin K, which reflects recent intake more than tissue status. The research-grade markers are indirect: undercarboxylated osteocalcin, sometimes written ucOC, and dephosphorylated-uncarboxylated matrix Gla protein, dp-ucMGP. High levels of the uncarboxylated forms suggest your K2 is not keeping up with demand. These tests live mainly in research settings and are not part of standard care, so for most people the practical move is to secure the dietary sources rather than chase a number.

The low-drama conclusion. You probably cannot easily test your K2 status, and you probably do not need to. If you eat some combination of cheese, eggs, fermented foods and the occasional pastured animal product, you are likely in reasonable shape. If your diet is genuinely thin on all of those, that is the signal to add them, or to consider a modest MK-7 supplement, with the warfarin caveat firmly in mind.

Where a gum honestly fits, and where it does not

It would be easy, and dishonest, for a chewing gum company to imply its product delivers the benefits of vitamin K2. It does not, and the reason is worth stating plainly. K2 is a fat-soluble nutrient that works systemically, absorbed through the gut with dietary fat and acting over weeks on proteins deep in bone and dentin. A gum you chew for a few minutes is a surface tool. These are two different mechanisms operating in two different places, and no amount of marketing collapses that gap.

What a remineralizing gum can do is act on the enamel surface, the exact place K2 cannot reach. Chewing stimulates saliva, which is your own delivery system for calcium and phosphate and your main buffer against acid, and a gum carrying hydroxyapatite adds mineral to that surface environment while you chew. That is genuinely complementary to a good K2 intake rather than a substitute for it. One works from the outside on the shell, the other works from the inside on the living matrix, and neither replaces fluoride brushing, which remains the backbone of any routine.

This is where Minvelle sits honestly. It is a remineralizing gum, not a vitamin, and it makes no claim on your calcium metabolism. You chew one piece a day, an 18-piece box lasts 18 days, and its job is to support the enamel surface between brushings, not to do anything K2 does inside the body. If someone tells you a single product covers both the systemic mineral direction that K2 governs and the surface remineralization a gum supports, they are overselling, because those are separate jobs and will always be separate jobs.

The combined routine that actually makes sense. Brush with fluoride, because that is the intervention with the deepest evidence. Eat for adequate K2 and vitamin D so your body can place calcium properly in bone and dentin. Support the enamel surface with saliva, and if you like, a remineralizing gum after meals. Each layer does a job the others cannot. That is a real routine, and it is more honest and more effective than any single miracle nutrient.

The things people actually ask